Protalix BioTherapeutics ... (PLX)

AMEX: PLX · Real-Time Price · USD

2.99

-0.08 (-2.61%)

At close: May 01, 2025, 3:59 PM

3.02

0.94%

Pre-market: May 02, 2025, 09:00 AM EDT

Protalix BioTherapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	53.4M	65.49M	47.64M	38.35M	62.9M	54.69M	34.24M	19.24M	9.2M
Cost of Revenue	24.32M	22.98M	19.59M	16.35M	10.87M	10.89M	9.3M	15.23M	8.4M
Gross Profit	29.08M	42.51M	28.05M	22M	52.02M	43.8M	24.94M	4.01M	801K
Operating Income	3.92M	10.46M	-13.01M	-20.46M	1.85M	-10.72M	-19.31M	-36.35M	-33.16M
Interest Income	1.3M	1.29M	1.15M	401K	438K	407K	536K	188K	589K
Pretax Income	4.15M	8.57M	-14.4M	-27.58M	-6.52M	-18.28M	-26.46M	-85.28M	-29.18M
Net Income	2.93M	8.31M	-14.93M	-33.98M	-14.89M	-26.24M	-26.46M	-85.28M	-29.36M
Selling & General & Admin	12.19M	14.96M	11.71M	12.73M	11.15M	9.9M	10.92M	11.53M	9.36M
Research & Development	12.97M	17.09M	29.35M	29.73M	38.17M	44.62M	33.33M	28.83M	24.61M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	25.16M	32.05M	41.06M	42.46M	49.31M	54.52M	44.25M	40.36M	33.96M
Interest Expense	1.06M	3.18M	2.53M	7.52M	9.67M	7.97M	7.68M	9.72M	10.66M
Selling & Marketing Expenses	52.98M	n/a	25.29M	16.75M	16.24M	15.87M	8.98M	n/a	n/a
Cost & Expenses	49.48M	55.03M	60.65M	58.81M	60.19M	65.41M	53.55M	55.59M	42.36M
Income Tax Expense	1.22M	254K	530K	6.4M	8.37M	7.97M	536K	7.8M	10.85M
Shares Outstanding (Basic)	72.53M	67.51M	48.47M	44.14M	29.15M	14.84M	14.71M	13.11M	101.39M
Shares Outstanding (Diluted)	81.06M	82.42M	48.47M	44.14M	29.15M	14.84M	14.71M	13.11M	101.39M
EPS (Basic)	0.04	0.12	-0.31	-0.77	-0.51	-1.77	-1.8	-6.51	-0.29
EPS (Diluted)	0.04	0.10	-0.31	-0.77	-0.51	-1.77	-1.8	-6.51	-0.29
EBITDA	6.52M	11.65M	-10.78M	-18.94M	4.45M	-8.69M	-17.1M	-71.8M	-16.53M
EBIT	5.22M	10.46M	-11.87M	-20.06M	2.71M	-10.31M	-18.77M	-73.72M	-24.98M
Depreciation & Amortization	1.3M	1.19M	1.09M	1.12M	1.3M	1.62M	1.67M	1.92M	1.98M